Review
The Role of Cytokines in the Pathogenesis of Acute Pancreatitis

https://doi.org/10.1016/S0002-9610(97)00240-7Get rights and content

Abstract

Background: The systemic manifestations of acute pancreatitis are responsible for the majority of pancreatitis-associated morbidity and mortality and are now believed to be due to the actions of specific inflammatory cytokines. This report summarizes what is known about the role of cytokines in the pathogenesis of acute pancreatitis.

Methods: Comprehensive literature review of experimental pancreatitis as well as all reports of cytokine involvement during clinical pancreatitis.

Results: Several cytokines and other noncytokine inflammatory mediators are produced rapidly during pancreatitis. These mediators arise in many tissues in a predictable fashion independent of the animal model used or the underlying etiology in human disease. Preventing the activities of these mediators has a profound beneficial effect in experimental animals.

Conclusions: A few recently described inflammatory mediators are believed to be primarily responsible for the systemic manifestations of acute pancreatitis and its associated distant organ dysfunction. The predictable nature in which they are produced may allow for novel approaches to treating this disease.

Section snippets

Historical Perspective

Many research efforts during the past several decades have attempted to attenuate pancreatitis severity through inhibiting the deranged intracellular processes that occur within the acinar cell during AP. Investigators felt that identifying the initiating event that results in intracellular enzyme activation would lead to appropriate clinical therapies.1, 5, 6 This approach has had nominal success, however, and the initiating event in this cascade continues to elude detection. Similarly, a

References (99)

  • G Fink et al.

    Acute pancreatitis induced enzyme release and necrosis are attenuated by IL-1 antagonism though an indirect mechanism

    J Surg Res

    (1997)
  • NJ Dusetti et al.

    Induction of lithostathine/reg mRNA expression by serum from rats with acute-pancreatitis and cytokes in pancreatic acinar AR-42J cells

    Arch Biochem Biophys

    (1996)
  • NJ Dusetti et al.

    Pancreatitis-associated protein I (PAP I), an acute phase protein induced by cytokinesIdentification of two functional interleukin-6 response elements in the rat PAP I promoter region

    J Biol Chem

    (1995)
  • JG Norman et al.

    Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1beta gene expression at steady-state and during the systemic stress induced by the acute pancreatitis

    J Surg Res

    (1996)
  • W Denham et al.

    Transgenic animals demonstrate modest additive detrimental effects of IL-1 and TNF during acute pancreatitis

    Gastroenterology

    (1997)
  • S Nagata

    Apoptosis by death factor

    Cell

    (1997)
  • K Guice et al.

    Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis

    J Surg Res

    (1991)
  • CB Hughes et al.

    Induction of acute pancreatitis in germ-free ratsevidence of a primary role for tumor necrosis factor-alpha

    Surgery

    (1995)
  • HP Grewal et al.

    Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-a polyclonal antibody

    Am J Surg

    (1994)
  • CB Hughes et al.

    Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat

    Am J Surg

    (1996)
  • J Norman et al.

    Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis

    Surgery

    (1996)
  • JG Norman et al.

    Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis

    Surgery

    (1995)
  • JL Van Laethem et al.

    Interleukin 10 prevents necrosis in murine experimental acute pancreatitis

    Gastroenterology

    (1995)
  • AJ Rongione et al.

    Interleukin 10 reduces the severity of acute pancreatitis in rats

    Gastroenterology

    (1997)
  • AJ Rongione et al.

    Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis

    J Gastrointest Surg

    (1997)
  • W Denham et al.

    Cationic liposome-mediated gene transfer during acute pancreatitistissue specificity, duration, and effects of acute inflammation

    J Gastrointest Surg

    (1998)
  • SD Leach et al.

    New perspectives on acute pancreatitis

    Scand J Gastroenterol

    (1992)
  • W Steinberg et al.

    Acute pancreatitis

    NEJM

    (1994)
  • ML Jacobs et al.

    Acute pancreatitisanalysis of factors influencing survival

    Ann Surg

    (1977)
  • P Banks

    Predictors of severity in acute pancreatitis

    Pancreas

    (1991)
  • ML Steer

    How and where does acute pancreatitis begin?

    Arch Surg

    (1992)
  • JR Bettinger et al.

    Intracellular events in the pathogenesis of acute pancreatitis

    Pancreas

    (1991)
  • L Carey

    Extra-abdominal manifestations of acute pancreatitis

    Surgery

    (1979)
  • JHC Ranson et al.

    The role of peritoneal lavage in severe acute pancreatitis

    Ann Surg

    (1978)
  • HH Stone et al.

    Peritoneal dialysis in the treatment of acute alcoholic pancreatitis

    Surg Gynecol Obstet

    (1980)
  • AD Mayer et al.

    Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis

    NEJM

    (1985)
  • W Denham et al.

    Pancreatic ascites as a powerful inducer of inflammatory cytokinesrole of known versus unknown factors

    Arch Surg

    (1997)
  • R Seelig et al.

    The serum complement system—a mediator of acute pancreatitis

    Virchows Arch (Path Anat)

    (1975)
  • JT Whicher et al.

    Complement activation and complement control proteins in acute pancreatitis

    Gut

    (1982)
  • SW Galloway et al.

    Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist

    Pancreas

    (1996)
  • W Chao et al.

    Platelet-activating factorreceptors and signal transduction

    Biochemical J

    (1993)
  • AN Kingsnorth et al.

    Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

    Br J Surg

    (1995)
  • AN Kingsnorth

    Early treatment with lexipafant, a platelet activating factor antagonist reduces mortality in acute pancreatitisa double blind, randomized, placebo controlled study

    Gastroenterology

    (1997)
  • Y Kikuchi et al.

    The role of nitric oxide in mouse cerulein-induced pancreatitis with and without lipopolysaccharide pretreatment

    Pancreas

    (1996)
  • TA Creagh et al.

    Oxygen free radicals and acute pancreatitisfact or fiction?

    IJMS

    (1993)
  • C Niederau et al.

    Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis

    Pancreas

    (1992)
  • FS di Giovine et al.
  • CJ Dinarello

    The interleukin-1 family10 years of discovery

    FASEB J

    (1994)
  • A Aderem

    How cytokines signal messages within cells

    J Infect Dis

    (1993)
  • Cited by (685)

    View all citing articles on Scopus
    View full text